Polly A. Murphy Atea Pharmaceuticals, Inc. (AVIR) insider trading activity

AVIR Quotes by TradingView

Polly A. Murphy is of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 56,445 shares of AVIR, which is worth approximately $185,139. The most recent transaction as insider was on Jun 16, 2024, when has been sold 33,150 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.4K
142.31% 3M change
142.31% 12M change
Total Value Held $185,139

Polly A. Murphy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2024
BUY
Exercise of conversion of derivative security
-
33,150 Added 37.0%
56,445 Common Stock
Dec 20 2021
BUY
Open market or private purchase
$102,840 $8.57 p/Share
12,000 Added 34.0%
23,295 Common Stock

Also insider at

CELC
Celcuity Inc. Healthcare
Director
PAM

Polly A. Murphy

Minneapolis, MN

Track Institutional and Insider Activities on AVIR

Follow Atea Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVIR shares.

Notify only if

Insider Trading

Get notified when an Atea Pharmaceuticals, Inc. insider buys or sells AVIR shares.

Notify only if

News

Receive news related to Atea Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVIR